Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19
Sponsor: Rutgers, The State University of New Jersey
Terminated
Ineffectiveness of treatment
Other terminated trials from Rutgers, The State University of New Jersey
- Pain Management · Phase PHASE4 · Dec 2024
- ICU Delirium · Phase NA · Jun 2024
- Breast Cancer · Phase NA · Aug 2023
- Muscle Soreness · Phase NA · Jun 2022
- Other Biomechanical Lesions of Upper Extremity · Phase NA · Mar 2021
See all terminations from Rutgers, The State University of New Jersey
This PHASE2 trial investigates COVID-19 and SARS-CoV-2 and is currently terminated or withdrawn. Rutgers, The State University of New Jersey leads this study, which shows 8 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Mar 2023 — Jul 2024 [monthly]
Terminated PHASE2
Status: Active Not Recruiting → Terminated
-
Oct 2021 — Mar 2023 [monthly]
Active Not Recruiting PHASE2
-
Mar 2021 — Oct 2021 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
▶ Show 3 earlier versions
-
Jan 2021 — Mar 2021 [monthly]
Recruiting PHASE2
-
Jun 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
May 2020 — Jun 2020 [monthly]
Recruiting PHASE2
First recorded
Apr 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Rutgers, The State University of New Jersey
For direct contact, visit the study record on ClinicalTrials.gov .